Hochschulschrift
Impact of the nitric oxide-independent soluble guanylate cyclase activator cinaciguat on restenosis after arterial injury in rats
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
vii, 67 Seiten
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Ruprecht-Karls-Universität Heidelberg, Dissertation, 2016
- Classification
-
Medizin, Gesundheit
- Creator
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 2:12 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Other Objects (12)
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation
Structural studies of soluble guanylate cyclase
Lessons from soluble guanylate cyclase alpha1 knockouts
Molecular steps in soluble guanylate cyclase activation
Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
The role of soluble guanylate cyclase in metabolism
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
Role of soluble guanylate cyclase in progressive renal fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation
Structural studies of soluble guanylate cyclase
Lessons from soluble guanylate cyclase alpha1 knockouts
Molecular steps in soluble guanylate cyclase activation
Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
The role of soluble guanylate cyclase in metabolism
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
Role of soluble guanylate cyclase in progressive renal fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Activation of soluble guanylate cyclase by nitric oxide in lymphocytes correlates with minimal hepatic encephalopathy in cirrhotic patients
Discovery of the Soluble Guanylate Cyclase Activator Runcaciguat (BAY 1101042)
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation
Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteosomal degradation
Structural studies of soluble guanylate cyclase
Lessons from soluble guanylate cyclase alpha1 knockouts
Molecular steps in soluble guanylate cyclase activation
Antiplatelet effects of aspirin are not affected by the soluble guanylate cyclase activator cinaciguat (BAY 58-2667)
The role of soluble guanylate cyclase in metabolism
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
Role of soluble guanylate cyclase in progressive renal fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis